Phase 3 Breakthroughs: Hear from the Companies Behind Three Pivotal Clinical Trials - GRICON 2025
Автор: CureGRIN Foundation
Загружено: 2025-07-31
Просмотров: 104
This video offers an unprecedented look at the forefront of therapeutic development for GRI Disorders. We bring together executives from three leading biopharma companies currently conducting Phase 3 clinical trials for which GRI Disorder patients are eligible. Hear directly from representatives of GRIN Therapeutics, Longboard/Lundbeck Pharmaceuticals, and Praxis as they share critical updates on their pivotal studies. This is a unique opportunity to gain insights into the progress, potential, and next steps for these late-stage trials, representing a significant stride towards new treatments for the GRI community.
All other content from GRICON25 can be viewed by registering here: https://curegrinfoundation.salsalabs....
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
